- Home
- EVC vs ACHV Comparison
EVC vs ACHV Comparison
Compare EVC & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- ACHV
- Stock Information
- Founded
- EVC 1996
- ACHV N/A
- Country
- EVC United States
- ACHV Canada
- Employees
- EVC N/A
- ACHV N/A
- Industry
- EVC Broadcasting
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EVC Industrials
- ACHV Health Care
- Exchange
- EVC Nasdaq
- ACHV Nasdaq
- Market Cap
- EVC 229.5M
- ACHV 126.9M
- IPO Year
- EVC 2000
- ACHV N/A
- Fundamental
- Price
- EVC $2.42
- ACHV $3.15
- Analyst Decision
- EVC Hold
- ACHV Strong Buy
- Analyst Count
- EVC 1
- ACHV 5
- Target Price
- EVC $1.75
- ACHV $14.80
- AVG Volume (30 Days)
- EVC 608.7K
- ACHV 260.4K
- Earning Date
- EVC 03-04-2025
- ACHV 11-07-2024
- Dividend Yield
- EVC 8.33%
- ACHV N/A
- EPS Growth
- EVC N/A
- ACHV N/A
- EPS
- EVC N/A
- ACHV N/A
- Revenue
- EVC $1,146,066,000.00
- ACHV N/A
- Revenue This Year
- EVC N/A
- ACHV N/A
- Revenue Next Year
- EVC N/A
- ACHV N/A
- P/E Ratio
- EVC N/A
- ACHV N/A
- Revenue Growth
- EVC 122.49
- ACHV N/A
- 52 Week Low
- EVC $1.33
- ACHV $3.12
- 52 Week High
- EVC $4.41
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- EVC 49.96
- ACHV 26.85
- Support Level
- EVC $2.21
- ACHV $3.50
- Resistance Level
- EVC $2.70
- ACHV $3.86
- Average True Range (ATR)
- EVC 0.16
- ACHV 0.20
- MACD
- EVC 0.01
- ACHV -0.03
- Stochastic Oscillator
- EVC 41.84
- ACHV 4.05
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.